1Kosmidis PA, Kalofonos HP, Christodoulou C, et al. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer: a phase Ⅲ study of the Hellenic Cooperative Oncology Group. Ann Oncol, 2008, 19 : 115- 122.
2Rajeswaran A, Trojan A, Bumand B, et al. Efficacy and side effects of cisplatin-and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer, 2008, 59 : 1-11.
3Kortsik C, Albrecht P, Elmer A. Gemcitabine and carboplatin in patients with locally advanced or metastatic non-small cell lung cancer: a prospective phase Ⅲ study. Lung Cancer, 2003, 40: 85 -90.
4Bunn PA Jr:Chemotherapy for advanced non-small-cell lung cancer:who,what,when,why[J].J Clin Oncol,2002,20(18 Suppl):20S-33S.
5Rosll R,Gatzemeier U,Betticher DC,et al.Phase Ⅲ randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer:a cooperative multinational trial[J].Ann Oncol,2002,13(10):1539-1549.
6Fossella F,Pereira JR,Von Pawel J,et al.Randomized,multinational,phase Ⅲ study of docetaxel plus platinum combination vs vinorelbine plus cisplatin for advanced non-small-cell lung cancer:The TAX326 Study Group[J].J Clin Oncol,2003,21(16):3016-3024.
7Mazzanti P,Massacesi C,Rocchi MB,et al.Randomized,multicenter,phase Ⅱ study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer[J].Lung Cancer,2003,41(1):81-89.
8Go RS,Adjei AA.Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin[J].J Clin Oncol,1999,17(1):409-422.
9Wani MC,Taylor HL,Wall ME,et al.Plant antitumor agents,VI.The isolation and structure of taxol,a novel antileukemic and antitumor agent from taxus brevifolia[J].J Am Chem Soc,1971,93(9):2325-2327.
10Hamel E,Lin CM,Johns DG.Tubulin-dependent biochemical assay for the antineoplastic agent taxol and applications to measurements of the drug in the serum[J].Cancer Treat Rep,1982,66(6):1381-1386.
2Hardy D, Cormier JN, Xing Y, et al.Chemotherapy- associated toxicity in a large cohort of elderly patients with non-small cell lung cancer[J].J Thorac Oncol, 2010, 5(1):90.
3Hollen P J, Gralla RJ, Kris MG, et al. Quality of Life Assessment in Individuals with Lung Cancer:Testing the Lung Cancer Symptom Scale(LCSS)[J].Eur J Cancer, 1993, 29A(SuoD1 1):$51.
4Heukamp LC, Biittner R. Molecular diagnostics in lung carcinoma for therapy stratification[J].Pathologe, 2010, 31(1):22.
